Global Parenteral Formula Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Parenteral formulas are specialized liquid formulations administered intravenously to provide essential nutrients and fluids to individuals who are unable to obtain adequate nutrition through oral or enteral routes. Parenteral formulas are typically prescribed for patients with severe gastrointestinal disorders, malabsorption syndromes, or other medical conditions that impair their ability to absorb nutrients from food.
The global Parenteral Formula market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Parenteral Formula Industry Forecast” looks at past sales and reviews total world Parenteral Formula sales in 2023, providing a comprehensive analysis by region and market sector of projected Parenteral Formula sales for 2024 through 2030. With Parenteral Formula sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parenteral Formula industry.
This Insight Report provides a comprehensive analysis of the global Parenteral Formula landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Parenteral Formula portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Parenteral Formula market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parenteral Formula and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parenteral Formula.
United States market for Parenteral Formula is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Parenteral Formula is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Parenteral Formula is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Parenteral Formula players cover Baxter International lnc., B.Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc., Sichuan Kelun Pharmaceutical Co.,Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Parenteral Formula market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Parenteral Formula market?
What factors are driving Parenteral Formula market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Parenteral Formula market opportunities vary by end market size?
How does Parenteral Formula break out by Type, by Application?
Parenteral formulas are specialized liquid formulations administered intravenously to provide essential nutrients and fluids to individuals who are unable to obtain adequate nutrition through oral or enteral routes. Parenteral formulas are typically prescribed for patients with severe gastrointestinal disorders, malabsorption syndromes, or other medical conditions that impair their ability to absorb nutrients from food.
The global Parenteral Formula market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Parenteral Formula Industry Forecast” looks at past sales and reviews total world Parenteral Formula sales in 2023, providing a comprehensive analysis by region and market sector of projected Parenteral Formula sales for 2024 through 2030. With Parenteral Formula sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parenteral Formula industry.
This Insight Report provides a comprehensive analysis of the global Parenteral Formula landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Parenteral Formula portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Parenteral Formula market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parenteral Formula and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parenteral Formula.
United States market for Parenteral Formula is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Parenteral Formula is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Parenteral Formula is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Parenteral Formula players cover Baxter International lnc., B.Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc., Sichuan Kelun Pharmaceutical Co.,Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Parenteral Formula market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Carbohydrates
- Amino Acids
- Lipids
- Electrolytes
- Vitamins and Minerals
- Specialty Formulas
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Baxter International lnc.
- B.Braun Melsungen AG
- Fresenius Kabi AG
- Hospira, Inc.
- Sichuan Kelun Pharmaceutical Co.,Ltd.
- Otsuka Pharmaceutical Co.,Ltd.
- Grifols, S.A.
- Aculife Healthcare Private Limited
- Vifor Pharma Group
- Terumo Corporation
- Nutricia
What is the 10-year outlook for the global Parenteral Formula market?
What factors are driving Parenteral Formula market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Parenteral Formula market opportunities vary by end market size?
How does Parenteral Formula break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parenteral Formula Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Parenteral Formula by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Parenteral Formula by Country/Region, 2019, 2023 & 2030
2.2 Parenteral Formula Segment by Type
2.2.1 Carbohydrates
2.2.2 Amino Acids
2.2.3 Lipids
2.2.4 Electrolytes
2.2.5 Vitamins and Minerals
2.2.6 Specialty Formulas
2.3 Parenteral Formula Sales by Type
2.3.1 Global Parenteral Formula Sales Market Share by Type (2019-2024)
2.3.2 Global Parenteral Formula Revenue and Market Share by Type (2019-2024)
2.3.3 Global Parenteral Formula Sale Price by Type (2019-2024)
2.4 Parenteral Formula Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Parenteral Formula Sales by Application
2.5.1 Global Parenteral Formula Sale Market Share by Application (2019-2024)
2.5.2 Global Parenteral Formula Revenue and Market Share by Application (2019-2024)
2.5.3 Global Parenteral Formula Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Parenteral Formula Breakdown Data by Company
3.1.1 Global Parenteral Formula Annual Sales by Company (2019-2024)
3.1.2 Global Parenteral Formula Sales Market Share by Company (2019-2024)
3.2 Global Parenteral Formula Annual Revenue by Company (2019-2024)
3.2.1 Global Parenteral Formula Revenue by Company (2019-2024)
3.2.2 Global Parenteral Formula Revenue Market Share by Company (2019-2024)
3.3 Global Parenteral Formula Sale Price by Company
3.4 Key Manufacturers Parenteral Formula Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Parenteral Formula Product Location Distribution
3.4.2 Players Parenteral Formula Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PARENTERAL FORMULA BY GEOGRAPHIC REGION
4.1 World Historic Parenteral Formula Market Size by Geographic Region (2019-2024)
4.1.1 Global Parenteral Formula Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Parenteral Formula Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Parenteral Formula Market Size by Country/Region (2019-2024)
4.2.1 Global Parenteral Formula Annual Sales by Country/Region (2019-2024)
4.2.2 Global Parenteral Formula Annual Revenue by Country/Region (2019-2024)
4.3 Americas Parenteral Formula Sales Growth
4.4 APAC Parenteral Formula Sales Growth
4.5 Europe Parenteral Formula Sales Growth
4.6 Middle East & Africa Parenteral Formula Sales Growth
5 AMERICAS
5.1 Americas Parenteral Formula Sales by Country
5.1.1 Americas Parenteral Formula Sales by Country (2019-2024)
5.1.2 Americas Parenteral Formula Revenue by Country (2019-2024)
5.2 Americas Parenteral Formula Sales by Type (2019-2024)
5.3 Americas Parenteral Formula Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parenteral Formula Sales by Region
6.1.1 APAC Parenteral Formula Sales by Region (2019-2024)
6.1.2 APAC Parenteral Formula Revenue by Region (2019-2024)
6.2 APAC Parenteral Formula Sales by Type (2019-2024)
6.3 APAC Parenteral Formula Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Parenteral Formula by Country
7.1.1 Europe Parenteral Formula Sales by Country (2019-2024)
7.1.2 Europe Parenteral Formula Revenue by Country (2019-2024)
7.2 Europe Parenteral Formula Sales by Type (2019-2024)
7.3 Europe Parenteral Formula Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parenteral Formula by Country
8.1.1 Middle East & Africa Parenteral Formula Sales by Country (2019-2024)
8.1.2 Middle East & Africa Parenteral Formula Revenue by Country (2019-2024)
8.2 Middle East & Africa Parenteral Formula Sales by Type (2019-2024)
8.3 Middle East & Africa Parenteral Formula Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Parenteral Formula
10.3 Manufacturing Process Analysis of Parenteral Formula
10.4 Industry Chain Structure of Parenteral Formula
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Parenteral Formula Distributors
11.3 Parenteral Formula Customer
12 WORLD FORECAST REVIEW FOR PARENTERAL FORMULA BY GEOGRAPHIC REGION
12.1 Global Parenteral Formula Market Size Forecast by Region
12.1.1 Global Parenteral Formula Forecast by Region (2025-2030)
12.1.2 Global Parenteral Formula Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Parenteral Formula Forecast by Type (2025-2030)
12.7 Global Parenteral Formula Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Baxter International lnc.
13.1.1 Baxter International lnc. Company Information
13.1.2 Baxter International lnc. Parenteral Formula Product Portfolios and Specifications
13.1.3 Baxter International lnc. Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Baxter International lnc. Main Business Overview
13.1.5 Baxter International lnc. Latest Developments
13.2 B.Braun Melsungen AG
13.2.1 B.Braun Melsungen AG Company Information
13.2.2 B.Braun Melsungen AG Parenteral Formula Product Portfolios and Specifications
13.2.3 B.Braun Melsungen AG Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 B.Braun Melsungen AG Main Business Overview
13.2.5 B.Braun Melsungen AG Latest Developments
13.3 Fresenius Kabi AG
13.3.1 Fresenius Kabi AG Company Information
13.3.2 Fresenius Kabi AG Parenteral Formula Product Portfolios and Specifications
13.3.3 Fresenius Kabi AG Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Fresenius Kabi AG Main Business Overview
13.3.5 Fresenius Kabi AG Latest Developments
13.4 Hospira, Inc.
13.4.1 Hospira, Inc. Company Information
13.4.2 Hospira, Inc. Parenteral Formula Product Portfolios and Specifications
13.4.3 Hospira, Inc. Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Hospira, Inc. Main Business Overview
13.4.5 Hospira, Inc. Latest Developments
13.5 Sichuan Kelun Pharmaceutical Co.,Ltd.
13.5.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
13.5.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Product Portfolios and Specifications
13.5.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Main Business Overview
13.5.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Latest Developments
13.6 Otsuka Pharmaceutical Co.,Ltd.
13.6.1 Otsuka Pharmaceutical Co.,Ltd. Company Information
13.6.2 Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Product Portfolios and Specifications
13.6.3 Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Otsuka Pharmaceutical Co.,Ltd. Main Business Overview
13.6.5 Otsuka Pharmaceutical Co.,Ltd. Latest Developments
13.7 Grifols, S.A.
13.7.1 Grifols, S.A. Company Information
13.7.2 Grifols, S.A. Parenteral Formula Product Portfolios and Specifications
13.7.3 Grifols, S.A. Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Grifols, S.A. Main Business Overview
13.7.5 Grifols, S.A. Latest Developments
13.8 Aculife Healthcare Private Limited
13.8.1 Aculife Healthcare Private Limited Company Information
13.8.2 Aculife Healthcare Private Limited Parenteral Formula Product Portfolios and Specifications
13.8.3 Aculife Healthcare Private Limited Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Aculife Healthcare Private Limited Main Business Overview
13.8.5 Aculife Healthcare Private Limited Latest Developments
13.9 Vifor Pharma Group
13.9.1 Vifor Pharma Group Company Information
13.9.2 Vifor Pharma Group Parenteral Formula Product Portfolios and Specifications
13.9.3 Vifor Pharma Group Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Vifor Pharma Group Main Business Overview
13.9.5 Vifor Pharma Group Latest Developments
13.10 Terumo Corporation
13.10.1 Terumo Corporation Company Information
13.10.2 Terumo Corporation Parenteral Formula Product Portfolios and Specifications
13.10.3 Terumo Corporation Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Terumo Corporation Main Business Overview
13.10.5 Terumo Corporation Latest Developments
13.11 Nutricia
13.11.1 Nutricia Company Information
13.11.2 Nutricia Parenteral Formula Product Portfolios and Specifications
13.11.3 Nutricia Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Nutricia Main Business Overview
13.11.5 Nutricia Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parenteral Formula Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Parenteral Formula by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Parenteral Formula by Country/Region, 2019, 2023 & 2030
2.2 Parenteral Formula Segment by Type
2.2.1 Carbohydrates
2.2.2 Amino Acids
2.2.3 Lipids
2.2.4 Electrolytes
2.2.5 Vitamins and Minerals
2.2.6 Specialty Formulas
2.3 Parenteral Formula Sales by Type
2.3.1 Global Parenteral Formula Sales Market Share by Type (2019-2024)
2.3.2 Global Parenteral Formula Revenue and Market Share by Type (2019-2024)
2.3.3 Global Parenteral Formula Sale Price by Type (2019-2024)
2.4 Parenteral Formula Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Parenteral Formula Sales by Application
2.5.1 Global Parenteral Formula Sale Market Share by Application (2019-2024)
2.5.2 Global Parenteral Formula Revenue and Market Share by Application (2019-2024)
2.5.3 Global Parenteral Formula Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Parenteral Formula Breakdown Data by Company
3.1.1 Global Parenteral Formula Annual Sales by Company (2019-2024)
3.1.2 Global Parenteral Formula Sales Market Share by Company (2019-2024)
3.2 Global Parenteral Formula Annual Revenue by Company (2019-2024)
3.2.1 Global Parenteral Formula Revenue by Company (2019-2024)
3.2.2 Global Parenteral Formula Revenue Market Share by Company (2019-2024)
3.3 Global Parenteral Formula Sale Price by Company
3.4 Key Manufacturers Parenteral Formula Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Parenteral Formula Product Location Distribution
3.4.2 Players Parenteral Formula Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PARENTERAL FORMULA BY GEOGRAPHIC REGION
4.1 World Historic Parenteral Formula Market Size by Geographic Region (2019-2024)
4.1.1 Global Parenteral Formula Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Parenteral Formula Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Parenteral Formula Market Size by Country/Region (2019-2024)
4.2.1 Global Parenteral Formula Annual Sales by Country/Region (2019-2024)
4.2.2 Global Parenteral Formula Annual Revenue by Country/Region (2019-2024)
4.3 Americas Parenteral Formula Sales Growth
4.4 APAC Parenteral Formula Sales Growth
4.5 Europe Parenteral Formula Sales Growth
4.6 Middle East & Africa Parenteral Formula Sales Growth
5 AMERICAS
5.1 Americas Parenteral Formula Sales by Country
5.1.1 Americas Parenteral Formula Sales by Country (2019-2024)
5.1.2 Americas Parenteral Formula Revenue by Country (2019-2024)
5.2 Americas Parenteral Formula Sales by Type (2019-2024)
5.3 Americas Parenteral Formula Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parenteral Formula Sales by Region
6.1.1 APAC Parenteral Formula Sales by Region (2019-2024)
6.1.2 APAC Parenteral Formula Revenue by Region (2019-2024)
6.2 APAC Parenteral Formula Sales by Type (2019-2024)
6.3 APAC Parenteral Formula Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Parenteral Formula by Country
7.1.1 Europe Parenteral Formula Sales by Country (2019-2024)
7.1.2 Europe Parenteral Formula Revenue by Country (2019-2024)
7.2 Europe Parenteral Formula Sales by Type (2019-2024)
7.3 Europe Parenteral Formula Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parenteral Formula by Country
8.1.1 Middle East & Africa Parenteral Formula Sales by Country (2019-2024)
8.1.2 Middle East & Africa Parenteral Formula Revenue by Country (2019-2024)
8.2 Middle East & Africa Parenteral Formula Sales by Type (2019-2024)
8.3 Middle East & Africa Parenteral Formula Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Parenteral Formula
10.3 Manufacturing Process Analysis of Parenteral Formula
10.4 Industry Chain Structure of Parenteral Formula
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Parenteral Formula Distributors
11.3 Parenteral Formula Customer
12 WORLD FORECAST REVIEW FOR PARENTERAL FORMULA BY GEOGRAPHIC REGION
12.1 Global Parenteral Formula Market Size Forecast by Region
12.1.1 Global Parenteral Formula Forecast by Region (2025-2030)
12.1.2 Global Parenteral Formula Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Parenteral Formula Forecast by Type (2025-2030)
12.7 Global Parenteral Formula Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Baxter International lnc.
13.1.1 Baxter International lnc. Company Information
13.1.2 Baxter International lnc. Parenteral Formula Product Portfolios and Specifications
13.1.3 Baxter International lnc. Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Baxter International lnc. Main Business Overview
13.1.5 Baxter International lnc. Latest Developments
13.2 B.Braun Melsungen AG
13.2.1 B.Braun Melsungen AG Company Information
13.2.2 B.Braun Melsungen AG Parenteral Formula Product Portfolios and Specifications
13.2.3 B.Braun Melsungen AG Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 B.Braun Melsungen AG Main Business Overview
13.2.5 B.Braun Melsungen AG Latest Developments
13.3 Fresenius Kabi AG
13.3.1 Fresenius Kabi AG Company Information
13.3.2 Fresenius Kabi AG Parenteral Formula Product Portfolios and Specifications
13.3.3 Fresenius Kabi AG Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Fresenius Kabi AG Main Business Overview
13.3.5 Fresenius Kabi AG Latest Developments
13.4 Hospira, Inc.
13.4.1 Hospira, Inc. Company Information
13.4.2 Hospira, Inc. Parenteral Formula Product Portfolios and Specifications
13.4.3 Hospira, Inc. Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Hospira, Inc. Main Business Overview
13.4.5 Hospira, Inc. Latest Developments
13.5 Sichuan Kelun Pharmaceutical Co.,Ltd.
13.5.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
13.5.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Product Portfolios and Specifications
13.5.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Main Business Overview
13.5.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Latest Developments
13.6 Otsuka Pharmaceutical Co.,Ltd.
13.6.1 Otsuka Pharmaceutical Co.,Ltd. Company Information
13.6.2 Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Product Portfolios and Specifications
13.6.3 Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Otsuka Pharmaceutical Co.,Ltd. Main Business Overview
13.6.5 Otsuka Pharmaceutical Co.,Ltd. Latest Developments
13.7 Grifols, S.A.
13.7.1 Grifols, S.A. Company Information
13.7.2 Grifols, S.A. Parenteral Formula Product Portfolios and Specifications
13.7.3 Grifols, S.A. Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Grifols, S.A. Main Business Overview
13.7.5 Grifols, S.A. Latest Developments
13.8 Aculife Healthcare Private Limited
13.8.1 Aculife Healthcare Private Limited Company Information
13.8.2 Aculife Healthcare Private Limited Parenteral Formula Product Portfolios and Specifications
13.8.3 Aculife Healthcare Private Limited Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Aculife Healthcare Private Limited Main Business Overview
13.8.5 Aculife Healthcare Private Limited Latest Developments
13.9 Vifor Pharma Group
13.9.1 Vifor Pharma Group Company Information
13.9.2 Vifor Pharma Group Parenteral Formula Product Portfolios and Specifications
13.9.3 Vifor Pharma Group Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Vifor Pharma Group Main Business Overview
13.9.5 Vifor Pharma Group Latest Developments
13.10 Terumo Corporation
13.10.1 Terumo Corporation Company Information
13.10.2 Terumo Corporation Parenteral Formula Product Portfolios and Specifications
13.10.3 Terumo Corporation Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Terumo Corporation Main Business Overview
13.10.5 Terumo Corporation Latest Developments
13.11 Nutricia
13.11.1 Nutricia Company Information
13.11.2 Nutricia Parenteral Formula Product Portfolios and Specifications
13.11.3 Nutricia Parenteral Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Nutricia Main Business Overview
13.11.5 Nutricia Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Parenteral Formula Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Parenteral Formula Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Carbohydrates
Table 4. Major Players of Amino Acids
Table 5. Major Players of Lipids
Table 6. Major Players of Electrolytes
Table 7. Major Players of Vitamins and Minerals
Table 8. Major Players of Specialty Formulas
Table 9. Global Parenteral Formula Sales by Type (2019-2024) & (K Units)
Table 10. Global Parenteral Formula Sales Market Share by Type (2019-2024)
Table 11. Global Parenteral Formula Revenue by Type (2019-2024) & ($ million)
Table 12. Global Parenteral Formula Revenue Market Share by Type (2019-2024)
Table 13. Global Parenteral Formula Sale Price by Type (2019-2024) & (US$/Unit)
Table 14. Global Parenteral Formula Sale by Application (2019-2024) & (K Units)
Table 15. Global Parenteral Formula Sale Market Share by Application (2019-2024)
Table 16. Global Parenteral Formula Revenue by Application (2019-2024) & ($ million)
Table 17. Global Parenteral Formula Revenue Market Share by Application (2019-2024)
Table 18. Global Parenteral Formula Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global Parenteral Formula Sales by Company (2019-2024) & (K Units)
Table 20. Global Parenteral Formula Sales Market Share by Company (2019-2024)
Table 21. Global Parenteral Formula Revenue by Company (2019-2024) & ($ millions)
Table 22. Global Parenteral Formula Revenue Market Share by Company (2019-2024)
Table 23. Global Parenteral Formula Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers Parenteral Formula Producing Area Distribution and Sales Area
Table 25. Players Parenteral Formula Products Offered
Table 26. Parenteral Formula Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Parenteral Formula Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Parenteral Formula Sales Market Share Geographic Region (2019-2024)
Table 31. Global Parenteral Formula Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Parenteral Formula Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Parenteral Formula Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Parenteral Formula Sales Market Share by Country/Region (2019-2024)
Table 35. Global Parenteral Formula Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Parenteral Formula Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Parenteral Formula Sales by Country (2019-2024) & (K Units)
Table 38. Americas Parenteral Formula Sales Market Share by Country (2019-2024)
Table 39. Americas Parenteral Formula Revenue by Country (2019-2024) & ($ millions)
Table 40. Americas Parenteral Formula Sales by Type (2019-2024) & (K Units)
Table 41. Americas Parenteral Formula Sales by Application (2019-2024) & (K Units)
Table 42. APAC Parenteral Formula Sales by Region (2019-2024) & (K Units)
Table 43. APAC Parenteral Formula Sales Market Share by Region (2019-2024)
Table 44. APAC Parenteral Formula Revenue by Region (2019-2024) & ($ millions)
Table 45. APAC Parenteral Formula Sales by Type (2019-2024) & (K Units)
Table 46. APAC Parenteral Formula Sales by Application (2019-2024) & (K Units)
Table 47. Europe Parenteral Formula Sales by Country (2019-2024) & (K Units)
Table 48. Europe Parenteral Formula Revenue by Country (2019-2024) & ($ millions)
Table 49. Europe Parenteral Formula Sales by Type (2019-2024) & (K Units)
Table 50. Europe Parenteral Formula Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Parenteral Formula Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Parenteral Formula Revenue Market Share by Country (2019-2024)
Table 53. Middle East & Africa Parenteral Formula Sales by Type (2019-2024) & (K Units)
Table 54. Middle East & Africa Parenteral Formula Sales by Application (2019-2024) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Parenteral Formula
Table 56. Key Market Challenges & Risks of Parenteral Formula
Table 57. Key Industry Trends of Parenteral Formula
Table 58. Parenteral Formula Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Parenteral Formula Distributors List
Table 61. Parenteral Formula Customer List
Table 62. Global Parenteral Formula Sales Forecast by Region (2025-2030) & (K Units)
Table 63. Global Parenteral Formula Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Americas Parenteral Formula Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Americas Parenteral Formula Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. APAC Parenteral Formula Sales Forecast by Region (2025-2030) & (K Units)
Table 67. APAC Parenteral Formula Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Europe Parenteral Formula Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Europe Parenteral Formula Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Middle East & Africa Parenteral Formula Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Middle East & Africa Parenteral Formula Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Global Parenteral Formula Sales Forecast by Type (2025-2030) & (K Units)
Table 73. Global Parenteral Formula Revenue Forecast by Type (2025-2030) & ($ millions)
Table 74. Global Parenteral Formula Sales Forecast by Application (2025-2030) & (K Units)
Table 75. Global Parenteral Formula Revenue Forecast by Application (2025-2030) & ($ millions)
Table 76. Baxter International lnc. Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 77. Baxter International lnc. Parenteral Formula Product Portfolios and Specifications
Table 78. Baxter International lnc. Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 79. Baxter International lnc. Main Business
Table 80. Baxter International lnc. Latest Developments
Table 81. B.Braun Melsungen AG Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 82. B.Braun Melsungen AG Parenteral Formula Product Portfolios and Specifications
Table 83. B.Braun Melsungen AG Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. B.Braun Melsungen AG Main Business
Table 85. B.Braun Melsungen AG Latest Developments
Table 86. Fresenius Kabi AG Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 87. Fresenius Kabi AG Parenteral Formula Product Portfolios and Specifications
Table 88. Fresenius Kabi AG Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Fresenius Kabi AG Main Business
Table 90. Fresenius Kabi AG Latest Developments
Table 91. Hospira, Inc. Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 92. Hospira, Inc. Parenteral Formula Product Portfolios and Specifications
Table 93. Hospira, Inc. Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. Hospira, Inc. Main Business
Table 95. Hospira, Inc. Latest Developments
Table 96. Sichuan Kelun Pharmaceutical Co.,Ltd. Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 97. Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Product Portfolios and Specifications
Table 98. Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Sichuan Kelun Pharmaceutical Co.,Ltd. Main Business
Table 100. Sichuan Kelun Pharmaceutical Co.,Ltd. Latest Developments
Table 101. Otsuka Pharmaceutical Co.,Ltd. Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 102. Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Product Portfolios and Specifications
Table 103. Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Otsuka Pharmaceutical Co.,Ltd. Main Business
Table 105. Otsuka Pharmaceutical Co.,Ltd. Latest Developments
Table 106. Grifols, S.A. Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 107. Grifols, S.A. Parenteral Formula Product Portfolios and Specifications
Table 108. Grifols, S.A. Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Grifols, S.A. Main Business
Table 110. Grifols, S.A. Latest Developments
Table 111. Aculife Healthcare Private Limited Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 112. Aculife Healthcare Private Limited Parenteral Formula Product Portfolios and Specifications
Table 113. Aculife Healthcare Private Limited Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Aculife Healthcare Private Limited Main Business
Table 115. Aculife Healthcare Private Limited Latest Developments
Table 116. Vifor Pharma Group Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 117. Vifor Pharma Group Parenteral Formula Product Portfolios and Specifications
Table 118. Vifor Pharma Group Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Vifor Pharma Group Main Business
Table 120. Vifor Pharma Group Latest Developments
Table 121. Terumo Corporation Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 122. Terumo Corporation Parenteral Formula Product Portfolios and Specifications
Table 123. Terumo Corporation Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. Terumo Corporation Main Business
Table 125. Terumo Corporation Latest Developments
Table 126. Nutricia Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 127. Nutricia Parenteral Formula Product Portfolios and Specifications
Table 128. Nutricia Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Nutricia Main Business
Table 130. Nutricia Latest Developments
Table 1. Parenteral Formula Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Parenteral Formula Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Carbohydrates
Table 4. Major Players of Amino Acids
Table 5. Major Players of Lipids
Table 6. Major Players of Electrolytes
Table 7. Major Players of Vitamins and Minerals
Table 8. Major Players of Specialty Formulas
Table 9. Global Parenteral Formula Sales by Type (2019-2024) & (K Units)
Table 10. Global Parenteral Formula Sales Market Share by Type (2019-2024)
Table 11. Global Parenteral Formula Revenue by Type (2019-2024) & ($ million)
Table 12. Global Parenteral Formula Revenue Market Share by Type (2019-2024)
Table 13. Global Parenteral Formula Sale Price by Type (2019-2024) & (US$/Unit)
Table 14. Global Parenteral Formula Sale by Application (2019-2024) & (K Units)
Table 15. Global Parenteral Formula Sale Market Share by Application (2019-2024)
Table 16. Global Parenteral Formula Revenue by Application (2019-2024) & ($ million)
Table 17. Global Parenteral Formula Revenue Market Share by Application (2019-2024)
Table 18. Global Parenteral Formula Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global Parenteral Formula Sales by Company (2019-2024) & (K Units)
Table 20. Global Parenteral Formula Sales Market Share by Company (2019-2024)
Table 21. Global Parenteral Formula Revenue by Company (2019-2024) & ($ millions)
Table 22. Global Parenteral Formula Revenue Market Share by Company (2019-2024)
Table 23. Global Parenteral Formula Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers Parenteral Formula Producing Area Distribution and Sales Area
Table 25. Players Parenteral Formula Products Offered
Table 26. Parenteral Formula Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Parenteral Formula Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Parenteral Formula Sales Market Share Geographic Region (2019-2024)
Table 31. Global Parenteral Formula Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Parenteral Formula Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Parenteral Formula Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Parenteral Formula Sales Market Share by Country/Region (2019-2024)
Table 35. Global Parenteral Formula Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Parenteral Formula Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Parenteral Formula Sales by Country (2019-2024) & (K Units)
Table 38. Americas Parenteral Formula Sales Market Share by Country (2019-2024)
Table 39. Americas Parenteral Formula Revenue by Country (2019-2024) & ($ millions)
Table 40. Americas Parenteral Formula Sales by Type (2019-2024) & (K Units)
Table 41. Americas Parenteral Formula Sales by Application (2019-2024) & (K Units)
Table 42. APAC Parenteral Formula Sales by Region (2019-2024) & (K Units)
Table 43. APAC Parenteral Formula Sales Market Share by Region (2019-2024)
Table 44. APAC Parenteral Formula Revenue by Region (2019-2024) & ($ millions)
Table 45. APAC Parenteral Formula Sales by Type (2019-2024) & (K Units)
Table 46. APAC Parenteral Formula Sales by Application (2019-2024) & (K Units)
Table 47. Europe Parenteral Formula Sales by Country (2019-2024) & (K Units)
Table 48. Europe Parenteral Formula Revenue by Country (2019-2024) & ($ millions)
Table 49. Europe Parenteral Formula Sales by Type (2019-2024) & (K Units)
Table 50. Europe Parenteral Formula Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Parenteral Formula Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Parenteral Formula Revenue Market Share by Country (2019-2024)
Table 53. Middle East & Africa Parenteral Formula Sales by Type (2019-2024) & (K Units)
Table 54. Middle East & Africa Parenteral Formula Sales by Application (2019-2024) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Parenteral Formula
Table 56. Key Market Challenges & Risks of Parenteral Formula
Table 57. Key Industry Trends of Parenteral Formula
Table 58. Parenteral Formula Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Parenteral Formula Distributors List
Table 61. Parenteral Formula Customer List
Table 62. Global Parenteral Formula Sales Forecast by Region (2025-2030) & (K Units)
Table 63. Global Parenteral Formula Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Americas Parenteral Formula Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Americas Parenteral Formula Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. APAC Parenteral Formula Sales Forecast by Region (2025-2030) & (K Units)
Table 67. APAC Parenteral Formula Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Europe Parenteral Formula Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Europe Parenteral Formula Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Middle East & Africa Parenteral Formula Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Middle East & Africa Parenteral Formula Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Global Parenteral Formula Sales Forecast by Type (2025-2030) & (K Units)
Table 73. Global Parenteral Formula Revenue Forecast by Type (2025-2030) & ($ millions)
Table 74. Global Parenteral Formula Sales Forecast by Application (2025-2030) & (K Units)
Table 75. Global Parenteral Formula Revenue Forecast by Application (2025-2030) & ($ millions)
Table 76. Baxter International lnc. Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 77. Baxter International lnc. Parenteral Formula Product Portfolios and Specifications
Table 78. Baxter International lnc. Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 79. Baxter International lnc. Main Business
Table 80. Baxter International lnc. Latest Developments
Table 81. B.Braun Melsungen AG Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 82. B.Braun Melsungen AG Parenteral Formula Product Portfolios and Specifications
Table 83. B.Braun Melsungen AG Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. B.Braun Melsungen AG Main Business
Table 85. B.Braun Melsungen AG Latest Developments
Table 86. Fresenius Kabi AG Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 87. Fresenius Kabi AG Parenteral Formula Product Portfolios and Specifications
Table 88. Fresenius Kabi AG Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Fresenius Kabi AG Main Business
Table 90. Fresenius Kabi AG Latest Developments
Table 91. Hospira, Inc. Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 92. Hospira, Inc. Parenteral Formula Product Portfolios and Specifications
Table 93. Hospira, Inc. Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. Hospira, Inc. Main Business
Table 95. Hospira, Inc. Latest Developments
Table 96. Sichuan Kelun Pharmaceutical Co.,Ltd. Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 97. Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Product Portfolios and Specifications
Table 98. Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Sichuan Kelun Pharmaceutical Co.,Ltd. Main Business
Table 100. Sichuan Kelun Pharmaceutical Co.,Ltd. Latest Developments
Table 101. Otsuka Pharmaceutical Co.,Ltd. Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 102. Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Product Portfolios and Specifications
Table 103. Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Otsuka Pharmaceutical Co.,Ltd. Main Business
Table 105. Otsuka Pharmaceutical Co.,Ltd. Latest Developments
Table 106. Grifols, S.A. Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 107. Grifols, S.A. Parenteral Formula Product Portfolios and Specifications
Table 108. Grifols, S.A. Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Grifols, S.A. Main Business
Table 110. Grifols, S.A. Latest Developments
Table 111. Aculife Healthcare Private Limited Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 112. Aculife Healthcare Private Limited Parenteral Formula Product Portfolios and Specifications
Table 113. Aculife Healthcare Private Limited Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Aculife Healthcare Private Limited Main Business
Table 115. Aculife Healthcare Private Limited Latest Developments
Table 116. Vifor Pharma Group Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 117. Vifor Pharma Group Parenteral Formula Product Portfolios and Specifications
Table 118. Vifor Pharma Group Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Vifor Pharma Group Main Business
Table 120. Vifor Pharma Group Latest Developments
Table 121. Terumo Corporation Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 122. Terumo Corporation Parenteral Formula Product Portfolios and Specifications
Table 123. Terumo Corporation Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. Terumo Corporation Main Business
Table 125. Terumo Corporation Latest Developments
Table 126. Nutricia Basic Information, Parenteral Formula Manufacturing Base, Sales Area and Its Competitors
Table 127. Nutricia Parenteral Formula Product Portfolios and Specifications
Table 128. Nutricia Parenteral Formula Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Nutricia Main Business
Table 130. Nutricia Latest Developments
LIST OF FIGURES
Figure 1. Picture of Parenteral Formula
Figure 2. Parenteral Formula Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Parenteral Formula Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Parenteral Formula Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Parenteral Formula Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Parenteral Formula Sales Market Share by Country/Region (2023)
Figure 10. Parenteral Formula Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Carbohydrates
Figure 12. Product Picture of Amino Acids
Figure 13. Product Picture of Lipids
Figure 14. Product Picture of Electrolytes
Figure 15. Product Picture of Vitamins and Minerals
Figure 16. Product Picture of Specialty Formulas
Figure 17. Global Parenteral Formula Sales Market Share by Type in 2023
Figure 18. Global Parenteral Formula Revenue Market Share by Type (2019-2024)
Figure 19. Parenteral Formula Consumed in Hospital Pharmacies
Figure 20. Global Parenteral Formula Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 21. Parenteral Formula Consumed in Retail Pharmacies
Figure 22. Global Parenteral Formula Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 23. Parenteral Formula Consumed in Online Pharmacies
Figure 24. Global Parenteral Formula Market: Online Pharmacies (2019-2024) & (K Units)
Figure 25. Global Parenteral Formula Sale Market Share by Application (2023)
Figure 26. Global Parenteral Formula Revenue Market Share by Application in 2023
Figure 27. Parenteral Formula Sales by Company in 2023 (K Units)
Figure 28. Global Parenteral Formula Sales Market Share by Company in 2023
Figure 29. Parenteral Formula Revenue by Company in 2023 ($ millions)
Figure 30. Global Parenteral Formula Revenue Market Share by Company in 2023
Figure 31. Global Parenteral Formula Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Parenteral Formula Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Parenteral Formula Sales 2019-2024 (K Units)
Figure 34. Americas Parenteral Formula Revenue 2019-2024 ($ millions)
Figure 35. APAC Parenteral Formula Sales 2019-2024 (K Units)
Figure 36. APAC Parenteral Formula Revenue 2019-2024 ($ millions)
Figure 37. Europe Parenteral Formula Sales 2019-2024 (K Units)
Figure 38. Europe Parenteral Formula Revenue 2019-2024 ($ millions)
Figure 39. Middle East & Africa Parenteral Formula Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Parenteral Formula Revenue 2019-2024 ($ millions)
Figure 41. Americas Parenteral Formula Sales Market Share by Country in 2023
Figure 42. Americas Parenteral Formula Revenue Market Share by Country (2019-2024)
Figure 43. Americas Parenteral Formula Sales Market Share by Type (2019-2024)
Figure 44. Americas Parenteral Formula Sales Market Share by Application (2019-2024)
Figure 45. United States Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 46. Canada Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 47. Mexico Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 48. Brazil Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 49. APAC Parenteral Formula Sales Market Share by Region in 2023
Figure 50. APAC Parenteral Formula Revenue Market Share by Region (2019-2024)
Figure 51. APAC Parenteral Formula Sales Market Share by Type (2019-2024)
Figure 52. APAC Parenteral Formula Sales Market Share by Application (2019-2024)
Figure 53. China Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 54. Japan Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 55. South Korea Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 56. Southeast Asia Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 57. India Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 58. Australia Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 59. China Taiwan Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 60. Europe Parenteral Formula Sales Market Share by Country in 2023
Figure 61. Europe Parenteral Formula Revenue Market Share by Country (2019-2024)
Figure 62. Europe Parenteral Formula Sales Market Share by Type (2019-2024)
Figure 63. Europe Parenteral Formula Sales Market Share by Application (2019-2024)
Figure 64. Germany Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 65. France Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 66. UK Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 67. Italy Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 68. Russia Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 69. Middle East & Africa Parenteral Formula Sales Market Share by Country (2019-2024)
Figure 70. Middle East & Africa Parenteral Formula Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Parenteral Formula Sales Market Share by Application (2019-2024)
Figure 72. Egypt Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 73. South Africa Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 74. Israel Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 75. Turkey Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 76. GCC Countries Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Parenteral Formula in 2023
Figure 78. Manufacturing Process Analysis of Parenteral Formula
Figure 79. Industry Chain Structure of Parenteral Formula
Figure 80. Channels of Distribution
Figure 81. Global Parenteral Formula Sales Market Forecast by Region (2025-2030)
Figure 82. Global Parenteral Formula Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Parenteral Formula Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Parenteral Formula Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Parenteral Formula Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Parenteral Formula Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Parenteral Formula
Figure 2. Parenteral Formula Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Parenteral Formula Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Parenteral Formula Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Parenteral Formula Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Parenteral Formula Sales Market Share by Country/Region (2023)
Figure 10. Parenteral Formula Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Carbohydrates
Figure 12. Product Picture of Amino Acids
Figure 13. Product Picture of Lipids
Figure 14. Product Picture of Electrolytes
Figure 15. Product Picture of Vitamins and Minerals
Figure 16. Product Picture of Specialty Formulas
Figure 17. Global Parenteral Formula Sales Market Share by Type in 2023
Figure 18. Global Parenteral Formula Revenue Market Share by Type (2019-2024)
Figure 19. Parenteral Formula Consumed in Hospital Pharmacies
Figure 20. Global Parenteral Formula Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 21. Parenteral Formula Consumed in Retail Pharmacies
Figure 22. Global Parenteral Formula Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 23. Parenteral Formula Consumed in Online Pharmacies
Figure 24. Global Parenteral Formula Market: Online Pharmacies (2019-2024) & (K Units)
Figure 25. Global Parenteral Formula Sale Market Share by Application (2023)
Figure 26. Global Parenteral Formula Revenue Market Share by Application in 2023
Figure 27. Parenteral Formula Sales by Company in 2023 (K Units)
Figure 28. Global Parenteral Formula Sales Market Share by Company in 2023
Figure 29. Parenteral Formula Revenue by Company in 2023 ($ millions)
Figure 30. Global Parenteral Formula Revenue Market Share by Company in 2023
Figure 31. Global Parenteral Formula Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Parenteral Formula Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Parenteral Formula Sales 2019-2024 (K Units)
Figure 34. Americas Parenteral Formula Revenue 2019-2024 ($ millions)
Figure 35. APAC Parenteral Formula Sales 2019-2024 (K Units)
Figure 36. APAC Parenteral Formula Revenue 2019-2024 ($ millions)
Figure 37. Europe Parenteral Formula Sales 2019-2024 (K Units)
Figure 38. Europe Parenteral Formula Revenue 2019-2024 ($ millions)
Figure 39. Middle East & Africa Parenteral Formula Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Parenteral Formula Revenue 2019-2024 ($ millions)
Figure 41. Americas Parenteral Formula Sales Market Share by Country in 2023
Figure 42. Americas Parenteral Formula Revenue Market Share by Country (2019-2024)
Figure 43. Americas Parenteral Formula Sales Market Share by Type (2019-2024)
Figure 44. Americas Parenteral Formula Sales Market Share by Application (2019-2024)
Figure 45. United States Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 46. Canada Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 47. Mexico Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 48. Brazil Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 49. APAC Parenteral Formula Sales Market Share by Region in 2023
Figure 50. APAC Parenteral Formula Revenue Market Share by Region (2019-2024)
Figure 51. APAC Parenteral Formula Sales Market Share by Type (2019-2024)
Figure 52. APAC Parenteral Formula Sales Market Share by Application (2019-2024)
Figure 53. China Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 54. Japan Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 55. South Korea Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 56. Southeast Asia Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 57. India Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 58. Australia Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 59. China Taiwan Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 60. Europe Parenteral Formula Sales Market Share by Country in 2023
Figure 61. Europe Parenteral Formula Revenue Market Share by Country (2019-2024)
Figure 62. Europe Parenteral Formula Sales Market Share by Type (2019-2024)
Figure 63. Europe Parenteral Formula Sales Market Share by Application (2019-2024)
Figure 64. Germany Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 65. France Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 66. UK Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 67. Italy Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 68. Russia Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 69. Middle East & Africa Parenteral Formula Sales Market Share by Country (2019-2024)
Figure 70. Middle East & Africa Parenteral Formula Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Parenteral Formula Sales Market Share by Application (2019-2024)
Figure 72. Egypt Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 73. South Africa Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 74. Israel Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 75. Turkey Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 76. GCC Countries Parenteral Formula Revenue Growth 2019-2024 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Parenteral Formula in 2023
Figure 78. Manufacturing Process Analysis of Parenteral Formula
Figure 79. Industry Chain Structure of Parenteral Formula
Figure 80. Channels of Distribution
Figure 81. Global Parenteral Formula Sales Market Forecast by Region (2025-2030)
Figure 82. Global Parenteral Formula Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Parenteral Formula Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Parenteral Formula Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Parenteral Formula Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Parenteral Formula Revenue Market Share Forecast by Application (2025-2030)
